NKTR-214

Bristol-Myers to test Opdivo with Nektar drug for several cancers
Yahoo/Reuters
Tue, 09/27/16 - 10:47 am
Bristol-Myers Squibb
Opdivo
Nektar
NKTR-214
PD-1 inhibitors
cancer
Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:51 am
NKTR-214
Nektar
breast cancer
Nektar reports positive preclinical data for two oncology programs
The Fly on the Wall
Wed, 04/9/14 - 11:50 am
Nektar
NKTR-102
NKTR-214
breast cancer

Pages